Mammalian genomes harbor three CoREST genes. rcor1 encodes CoREST (CoREST1), and the paralogues rcor2 and rcor3 encode CoREST2 and CoREST3, respectively. Here, we describe specific properties of transcriptional complexes formed by CoREST proteins with the histone demethylase LSD1/KDM1A and histone deacetylases 1 and 2 (HDAC1/2) and the finding that all three CoRESTs are expressed in the adult rat brain. CoRESTs interact equally strongly with LSD1/KDM1A. Structural analysis shows that the overall conformation of CoREST3 is similar to that of CoREST1 complexed with LSD1/KDM1A. Nonetheless, transcriptional repressive capacity of CoREST3 is lower than that of CoREST1, which correlates with the observation that CoREST3 leads to a reduced LSD1/KDM1A catalytic efficiency. Also, CoREST2 shows a lower transcriptional repression than CoREST1, which is resistant to HDAC inhibitors. CoREST2 displays lower interaction with HDAC1/2, which is barely present in LSD1/KDM1A-CoREST2 complexes. A nonconserved leucine in the first SANT domain of CoREST2 severely weakens its association with HDAC1/2. Furthermore, CoREST2 mutants with increased HDAC1/2 interaction and those without HDAC1/2 interaction exhibit equivalent transcriptional repression capacities, indicating that CoREST2 represses in an HDAC-independent manner. In conclusion, differences among CoREST proteins are instrumental in the modulation of protein-protein interactions and catalytic activities of LSD1/KDM1A-CoREST-HDAC complexes, fine-tuning gene expression regulation.
G
ene expression regulation is exerted by activator or repressor transcriptional complexes that are targeted to specific loci in the chromatin. CoREST was initially described as a transcriptional corepressor for REST (repressor element 1-silencing transcription factor [1] ) and later purified as part of a transcriptional corepressor complex, comprising also the histone demethylase LSD1/ KDM1A and the histone deacetylases 1 and 2 (HDAC1/2) (2, 3), here referred to as the LCH complex. REST recruits CoREST to specifically repress the expression of neuronal genes in nonneuronal cells and neural stem cells (4, 5) . However, in neural stem cells, CoREST targets a group of genes which are not REST targets, suggesting other relevant mechanisms in neuronal specification (6, 7) . A variety of transcription factors have indeed been shown to interact with CoREST and/or LSD1/KDM1A, thus bringing the LCH complex to transiently repress or silence target genes in both neuronal and nonneuronal systems (8, 9) . For instance, in hematopoietic cells, the zinc finger transcription factor Gfi (growth factor independent) recruits CoREST to regulate the expression of target genes during erythroid differentiation (9, 10) . CoREST also controls the expression of certain genes during physiopathological processes, as exemplified by its participation in repressing the heat shock (11) and proinflammatory (12) responses.
The components of the LCH complex operate sequentially and interdependently to epigenetically modify histones in the vicinity of regulated genes. First, HDAC1/2 deacetylates the H3 histone tail, allowing LSD1/KDM1A to demethylate mono-and dimethylated lysine 4 of histone H3 (13) (14) (15) . The presence of CoREST in the complex is essential for the recognition of the nucleosomal substrate and its deacetylation and demethylation by HDAC1/2 and LSD1/KDM1A, respectively (14) (15) (16) (17) . CoREST is highly preserved throughout evolution, and homologs in Drosophila (18) , Xenopus (19) , and Caenorhabditis elegans (20) , where it regulates specific cell phenotypes acquisition (18, (20) (21) (22) , have been described. In humans, CoREST is encoded by the gene rcor1 and has 482 amino acids with a molecular mass of 66 kDa (1) . CoREST harbors three highly conserved domains: one ELM2 (Egl-27 and MTA homology 2) and two SANT (SWI/SNF, ADA, NCoR, and TFIIIB) domains (14) . The ELM2 and the first SANT domain (SANT1) participate in the interaction with HDAC1/2 (3, 16, (23) (24) (25) , whereas the second SANT domain (SANT2) binds to LSD1/ KDMA1, forming a very tight protein complex (15, 17, 26) .
Two other genes, rcor2 and rcor3, with strong homology to the CoREST (CoREST1 hereafter) gene have been found in humans and in other species (27, 28) . In humans, rcor2 encodes CoREST2, a protein of 523 amino acids, whereas rcor3 encodes CoREST3, a protein with four isoforms of 436, 449, 495, and 553 amino acids generated by alternative splicing. It has been shown that CoREST2 is capable of interacting with LSD1/KDM1A (29) , and CoREST3 has been copurified in LSD1/KDM1A complexes (15) . Although the three proteins exhibit high sequence identity, little is known about CoREST2 and CoREST3 transcriptional activities, their functional partnerships, and their expression profile in mammalian brain. Here we show the specific properties and functional partnerships of each CoREST protein and their expression in the adult rat brain.
MATERIALS AND METHODS

Animals.
Adult male Sprague-Dawley rats weighing 250 to 300 g were used. Rats were maintained on a 12-h-light/12-h-dark cycle with food and water available ad libitum. The procedures were conducted in accordance with national and institutional policies (Comisión Nacional de Investigación Científica y Tecnológica [CONICYT] and Pontificia Universidad Católica de Chile).
Cell culture conditions. HEK293 and HEK293T cell lines were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin and maintained at 37°C and 5% CO 2 .
Antibodies. Polyclonal anti-Gal4 DNA binding domain (DBD) (sc-577) and monoclonal anti-Myc (9E10) antibodies were obtained from Santa Cruz Biotechnology. Two monoclonal anti-CoREST1 antibodies were used: K72/8 from Neuromab and 612146 from BD Transduction Laboratories. Anti-HDAC1 (10E2), anti-HDAC2 (3F3), polyclonal antiMyc (ab9106), polyclonal anti-CoREST3 (ab76921), and polyclonal anti-LSD1/KDM1A (ab17721) antibodies were obtained from Abcam. Polyclonal antibodies against LSD1/KDM1A (2139) and CoREST1 (07-455) were obtained from Millipore. Polyclonal anti-CoREST2 (HPA021638) and anti-␣-tubulin (T5168) antibodies were obtained from Sigma.
Plasmids. To obtain recombinant Gal4-CoREST expression plasmids, full-length rat CoREST2 cDNA (NM_001013994.1) and rat CoREST3 cDNA (NM_001134985.1) were generated by PCR from pEXPRESS and cloned into the vector pSG424 in the KpnI and XbaI sites. The human Gal4-CoREST1 was described previously (1) . Human Myc-CoREST1 was subcloned from pcDNA-CoREST (1) into the vector pCS2ϩMT, which encodes a 6ϫ Myc epitope. Myc-CoREST2-and Myc-CoREST3-expressing plasmids were generated by PCR from pEXPRESS and cloned into pCS2ϩMT. Myc-CoREST2 lacking the ELM2 domain, Myc-CoREST2 with the ELM2 of CoREST1, and CoREST2 containing point mutations were generated using previously described protocols (30) . Mutants of CoREST2 were subcloned from pCS2ϩMT into pSG424 using standard cloning methods. All plasmids encoding fusion protein constructs were sequenced across the junction to confirm that inserts were in frame. All constructs generated by PCR were completely sequenced.
Coimmunoprecipitation and Western blotting. HEK293T cells (3.5 ϫ 10 6 cells) were transfected with 2.5 g of Myc-CoREST1, MycCoREST2, or Myc-CoREST3 and harvested 48 h after transfection. Coimmunoprecipitation assays and Western blot assays were carried out as described previously (11) . To quantify the amount of coprecipitated proteins (HDACs and LSD1/KDM1A), specific bands of Western blots were quantified with ImageJ software, and values were corrected by the relative amount of each Myc-CoREST protein precipitated.
Transient-transfection and reporter gene assays. Transient-transfection and reporter gene assays were performed as we described previously (30) . We used the reporter plasmid G5S4tkLuc, which encodes firefly luciferase and is driven by a system containing 5 upstream activation sequences (UAS) and four elements for the SP1 transcriptional activator, upstream of the thymidine kinase promoter (0.102 g), at molar ratios of 1:1, 1:0.5, and 1:0.25 relative to Gal4-CoREST expression vectors. Control experiments were carried out using equivalent molar amounts of the empty vector (pSG424) that encodes Gal4-DBD (amino acids 1 to 147). Suberoylanilide hydroxamic acid (SAHA; 0.5, 2.0, and 5.0 M) and trichostatin A (TSA; 0.03, 0.1, 0.5, 1.0, and 2.0 M) solutions or vehicle (dimethyl sulfoxide [DMSO] ) was added to cultured cells 24 h before cell harvesting.
In vitro histone deacetylation assay (HDAC assay). Immunoprecipitates with anti-Myc antibodies obtained from 2 mg of whole HEK293 cell extracts were tested for their associated histone deacetylase activity as we described previously (31) . Briefly, immunoprecipitates were incubated for 60 min with a short peptide substrate containing an acetylated lysine residue that can be deacetylated by class I, II, and IV HDAC enzymes. We used fluorescent acetylated histone peptides as the substrate (Active Motif, Inc., Carlsbad, CA) and measured HDAC activity as relative fluorescence units (RFU)/h. HeLa nuclear extract (5 g) was used as a positive control. Myc immunoprecipitates from mock-transfected cells were used as a negative control (see Fig. S2B in the supplemental material). The reaction was read using a Wallac 1420 Victor3 V microplate reader (PerkinElmer, Waltham, MA).
Immunofluorescence assays. Immunofluorescence assays were performed essentially as described previously (32) . Brain slices were incubated with anti-CoREST1 (612146 from BD Transduction Laboratories) for 48 h at 4°C, and then anti-CoREST2 (HPA021638 from Sigma) was added, followed by incubation for 12 h. Subsequently, slices were mounted on glass slides and incubated with secondary anti-rabbit IgG coupled to Alexa Fluor 594 and anti-mouse IgG coupled to Alexa Fluor 488. Finally, analysis and photomicrography were carried out with a confocal microscope (Olympus FV-1000).
Enzymatic studies. Escherichia coli overexpression, purification, and crystallization of the human LSD1/KDM1A-CoREST3 complex were carried out following the procedures previously described for LSD1/ KDM1A-CoREST1 (26) . Briefly, a His-SUMO-tagged recombinant form of LSD1/KDM1A (residues 123 to 852) was copurified with a glutathione S-transferase (GST)-tagged CoREST3 protein (residues 258 to 418 with reference to NP_001129695.1) by tandem-affinity chromatography followed by gel filtration on a Superdex200 column (GE Healthcare). The enzymatic activity of purified LSD1/KDM1A-CoREST3 was measured on a 21-residue H3-monomethylated peptide on Lys4 (Thermo Electron Corporation) by the peroxidase-coupled assay at 25°C using a Cary 100 UV/visible spectrophotometer (Varian Inc.) (33) . The demethylation reaction was performed by adding 1 M protein solution to the reaction mixtures (150 l) consisting of 50 mM HEPES-NaOH buffer (pH 7.5), 0.1 mM 4-aminoantipyrine, 1 mM 3.5-dichloro-2-hydroxybenzenesulfonic acid, 0.35 M horseradish peroxidase, and variable concentrations (2 to 100 M) of the monomethylated H3-K4 peptide. The best fit was obtained with the equation describing a competitive inhibition by using GraphPad Prism 5 software (Table 1) .
Structural biology. The LSD1/KDM1A-CoREST3 complex was crystallized by the hanging-drop vapor diffusion method at 20°C following previously described protocols (26) . The resulting crystals were screened at beamlines of the SLS and ESRF synchrotrons, and data processing and scaling were carried out using MOSFLM (34) and programs of the CCP4 package (1994). The structure of the LSD1/KDM1A-CoREST1 complex (26) (PDB entry 2V1D) was used as the initial model for refinement after removal of all water atoms. Crystallographic refinement ( Table 2) was performed with Refmac5 (35), and manual rebuilding was done with Coot (36) . Pictures were produced with CCP4MG software (http://www .ccp4.ac.uk/MG/). Vertebrate CoREST protein sequences available at National Center for Biotechnology Information (http://www.ncbi.nlm.nih .gov/protein) were compared. Protein sequence alignment (CoREST1, NP_055971.1; CoREST2, NP_775858.2; and the longest spliced variant of CoREST3 [CoREST3a], NP_001129695.1) was performed using the tools at the website of the European Bioinformatics Institute (http://www.ebi .ac.uk/Tools/msa/clustalw2/), and identity was calculated with the follow- 
RESULTS
CoREST2 and CoREST3 behave as transcriptional repressors.
To evaluate whether CoREST2 and CoREST3 are transcriptional repressors, like CoREST1, we performed luciferase reporter assays using a promoter harboring 5 upstream activation sequence (UAS) elements for the yeast transcription factor Gal4 and 4 elements for the mammalian transcription factor SP1, which confers a high basal transcriptional rate. All CoRESTs fused to the Gal4 DNA binding domain (DBD) significantly repressed the expression of the reporter (Fig. 1A) . CoREST1 showed the highest transcriptional repression among the three proteins. CoREST2 and CoREST3 exhibited transcriptional repression activities, although they were significantly lower than that of CoREST1 at all reporter/ repressor molar ratios (Fig. 1A) . Gal4-CoREST protein levels in HEK293T cells were equivalent, and the proteins were located in the nuclei of the cells, demonstrating that the differences observed in transcriptional repression were not due to differences in the expression levels and/or subcellular distribution of the proteins ( Fig. 1B; also, see Fig. S1 in the supplemental material). Epigenetic modifications mediated by CoREST1 depend on its interaction with HDAC1/2 and LSD1/KDM1A. In order to determine whether histone deacetylation activity is involved in CoREST2-and CoREST3-dependent transcriptional repression, we studied the effect of HDAC inhibitors (37) on the transcriptional repression of Gal4-CoREST recombinant proteins. As shown in Fig. 2A (also, see Table S1 in the supplemental material), SAHA reversed the transcriptional repressor effect of Gal4-CoR-EST1 and Gal4-CoREST3 in a concentration-dependent manner. Conversely, Gal4-CoREST2 maintained its transcriptional repression in the presence of SAHA (Fig. 2A) . Similar results were observed using TSA (Fig. 2B) . These data suggest that the repressor capacities of CoREST1 and CoREST3 but not of CoREST2 depend on HDACs sensitive to TSA and SAHA.
Differential interaction of CoREST proteins with HDAC1/2. These first observations prompted us to test the ability of CoREST2 and CoREST3 to interact with HDAC1/2 by coimmunoprecipitation assays. In line with data presented above, MycCoREST2 precipitated a significantly smaller amount of HDAC1 and HDAC2 than Myc-CoREST1 and Myc-CoREST3, which coprecipitated the deacetylases with similar efficiencies ( Fig. 3A and B; also, see Fig. S2A in the supplemental material). To further verify the different capacity of each CoREST protein to interact with HDAC1/2, we carried out in vitro histone deacetylase activity assays with each Myc-CoREST-isolated immunocomplex. We found that Myc-CoREST2 immunoprecipitates showed a significantly lower HDAC-associated enzymatic activity than MycCoREST1 and Myc-CoREST3 immunoprecipitates ( Fig. 3C ; (Fig. 3C) . Taken together, the data show that CoREST2 has a significantly lower capacity to form complexes with HDAC1/2.
A nonconserved leucine on SANT1 domain weakens the interaction of CoREST2 with HDACs. CoREST proteins are highly conserved through evolution, showing sequence identity ranging from 90% for CoREST1 to 95% for CoREST3, among reported mammal sequences, suggesting specific functions for each of them. To uncover particular features of CoREST2 explaining its lower interaction with HDACs, we compared human CoREST family members ( Fig. 4A ; also, see Fig. S3 in the supplemental material for complete CoREST sequence alignment).
First, we validated the notion that the ELM2 domain is essential for HDAC1/2 recruitment (23). As was reported for CoREST1 (24), we found that CoREST2 protein lacking the ELM2 domain (CoREST2⌬ELM2) completely lost its weak ability to precipitate HDAC2 (Fig. 4B) , and as expected, MycCoREST2⌬ELM2 immunoprecipitates displayed barely detectable HDAC enzymatic activity (Fig. 4C) . To reveal whether the differences in the ELM2 domain of CoREST2, compared with the ELM domains of CoREST1 and CoREST3, are responsible for its lower interaction with HDAC2, we switched the ELM2 domains between CoREST1 and CoREST2. The chimera CoREST2/ELM2(CoREST1), in which we replaced the ELM2 domain of CoREST2 with the ELM2 of CoREST1, had an increased capacity to precipitate HDAC2, which, however, was not accompanied by an equal increase in HDAC enzymatic activity ( Fig. 4B and C) . To uncover the residues of CoREST2 responsible for its lower capacity to interact with HDACs, we replaced four amino acids in the ELM2 domain of CoREST1 (Fig. 4A ) with those found in CoREST2 (F169L, N174D, I175V, and P183A). These residues stand out in the sequence alignment because they are located in the highly conserved C-terminal part of the ELM2 and are identical in CoREST1 and CoREST3 but not in CoREST2 (Fig. 4A) . However, these amino acid replacements on CoREST1 did not produce any effect on its interaction with HDAC1/2 (data not shown). Next we looked into the highly conserved SANT1 domain of CoRESTs, considering that many proteins that interact with class I HDACs also display the ELM2-SANT domain organization (23, 25) . From the sequence alignment of the ELM2-SANT1 domain of CoREST proteins (Fig. 4A) , we noticed that amino acid 165 in CoREST2 is a leucine, whereas in CoREST1, CoREST3, and other HDAC-interacting proteins, the corresponding amino acid is a serine or a threonine (38) . Remarkably, the mutation of leucine 165 to a serine in CoREST2 exhibited a drastic effect, inducing a significant increase in the capacity of CoREST2 to interact with HDAC2 (Fig. 4B) , which was corroborated by a notable HDAC activity associated with this mutant (Fig. 4C) . Altogether, the data indicate that leucine 165 in SANT1 is the main factor limiting the interaction of the ELM2-SANT1 domains of CoREST2 with HDAC1/2.
We studied whether the increased interaction and HDAC activity associated with the CoREST2L165S mutant resulted in a greater transcriptional repression capacity and/or sensitivity to the HDAC inhibitor SAHA. As shown in Fig. 4D , Gal4-CoREST2L165S displayed a transcriptional repression similar to that of wild-type Gal4-CoREST2, which is also insensitive to the presence of SAHA (Fig. 4D) . Furthermore, CoREST2 without the ELM2 domain displayed the same transcriptional repression as the wild type and was similarly insensitive to the presence of SAHA (Fig. 4D) . Taken together, the data indicate that CoREST2 transcriptional repression is independent of HDAC activity and it is mediated by a different domain than ELM2.
All CoREST proteins form complexes with LSD1/KDM1A. CoREST1 strongly interacts with LSD1/KDM1A, and it is essential for nucleosome demethylation (14, 15) . To see if CoREST2 and CoREST3 similarly interact with LSD1/KDM1A, we carried out coimmunoprecipitation assays. Myc-CoREST2 and Myc-CoREST3 interacted with LSD1/KDM1A with strength similar to that of Myc-CoREST1 (Fig. 5A ). Having discarded a defect in the interaction of CoREST2 and CoREST3 with LSD1/KDM1A, we evaluated whether the enzymatic activity of LSD1/KDM1A was affected when the demethylase was in complex with CoREST2 or CoREST3, considering that it is known that LSD1/KDM1A stability and full enzymatic activity depend on CoREST1 interaction (26) . Previous studies showed that LSD1/KDM1A-CoREST2 is active on the nucleosomes (29), but we were unable to further investigate the enzymatic properties of this complex, because recombinant CoREST2 proved to be biochemically intractable due to a strong tendency to aggregate. Conversely, the enzymatic properties of LSD1/KDM1A-CoREST3 could be investigated, revealing potentially significant differences compared to LSD1/ KDM1A-CoREST1. Specifically, the K m value for the substrate is Ͼ5-fold higher and is associated with a relevant 6-fold-lower k cat /K m ratio ( Table 1 ). The three-dimensional structural analysis of LSD1/KDM1A-CoREST3 shows that LSD1/KDM1A-CoREST3 adopts a conformation identical to that of a complex with CoREST1 ( Fig. 5B; Table 2 ). All amino acid changes (a total of 34 out of 133 residues visible in electron density) affect side chains on the protein surface, with no overall or local effects on the protein conformation. Nevertheless, these changes might exert some effects on catalysis (as gathered from the decreased k cat /K m ratio) through long-range electrostatic interactions affecting the binding of the highly charged N-terminal tail to the LSD1/KDM1A active site. Collectively, the data indicate that the lower transcriptional repressive capacity of CoREST3 than of CoREST1 is not due to a diminished interaction with LSD1/KDM1A, but it might arise from the lower catalytic efficiency, although other factors might also contribute to this effect.
CoREST type determines complex composition. The LCH complex exists as a multiprotein entity. Nonetheless, the data presented in this work suggest that the composition could be more dynamic than initially suspected. We wondered whether CoREST proteins determine the constitution of the complexes. First, we overexpressed LSD1/KDM1A with CoREST2 or CoREST3 in HEK293T cells and analyzed the presence of the endogenous HDAC1 and HDAC2 in LSD1/KDM1A-immunoprecipitated complexes. The results showed that when Myc-CoREST2 was overexpressed, LSD1/KDM1A complexes barely harbored HDAC1 and HDAC2 proteins (Fig. 6A) . In contrast, when MycCoREST3 was overexpressed, LSD1/KDM1A immunoprecipitation yielded substantial amounts of both HDAC1 and HDAC2 (Fig. 6B) . Next, we explored the ability of CoREST2 and CoREST3 to interact with CoREST1. Endogenous CoREST1 was strongly precipitated in complexes with Myc-CoREST1, whereas MycCoREST2 and Myc-CoREST3 showed a very low interaction with CoREST1 ( Fig. 6C and D) , confirmed by reverse coimmunoprecipitation (Fig. 6C, bottom) . Anti-Myc immunoprecipitates from mock-transfected cells did not show any CoREST1 signal, ruling out unspecific interaction (Fig. 6C) . These data confirm that CoREST proteins are the HDAC recruiters in the complex and support the existence of higher-order protein complexes between CoRESTs.
CoREST proteins share common brain territories. CoREST1 plays key roles in the regulation of neuronal gene expression (5) . To learn whether CoREST2 and CoREST3 accompany CoREST1 in regulating the expression of genes in mature neurons, we studied the expression of CoREST family in the adult rat brain. We performed different experimental approaches depending on the capacity of each specific antibody. We checked the specificity of each antibody by Western blot and immunofluorescence assays (see Fig. S4 in the supplemental material). Total protein extracts were obtained from different nuclei of adult rat brain, and Western blot assays were performed for the identification of CoREST1, CoREST3, and LSD1/KDM1A. Figure 7A shows that CoREST1, CoREST3, and LSD1/KDM1A are expressed in all tested brain nuclei, indicating ubiquitous expression of these proteins in the adult rat brain. Immunofluorescence assays revealed ample expression of CoREST2, with positive cells all over the cortex, hippocampus, and striatum, which were also positive for CoREST1 and/or CoREST3 ( Fig. 7B ; also, see Fig. S4 in the supplemental material for antibodies' specificity). Detailed observation of immunofluorescence in brain slices showed cells with no signal, sug- gesting that a few cells express little or no CoREST proteins. In addition, the intensity of green (CoREST1/CoREST3) and red (CoREST2) fluorescence in the hippocampus indicates that granular neurons of the dentate gyrus express more CoREST1 (or CoREST3) than CoREST2, in contrast to the hilum, where a more intense signal for CoREST2 is observed, and a few cells show only CoREST2-positive immunofluorescence (Fig. 7B) . Together, the data indicate a wide expression of CoREST proteins in the brain, with a variable degree of colocalization in different cells.
DISCUSSION
The presence of 3 rcor genes in 5 classes of vertebrates is indicative that these genes were present in a common vertebrate ancestor and have been preserved throughout evolution. As stated by Presgraves (39) , duplicate genes survive because they evolve new and essential functions. The data presented here show that transcriptional complexes formed by CoREST proteins have different protein compositions and transcriptional repressor strengths, suggesting that each CoREST-containing complex has evolved different and essential functions.
The data shown indicate that CoREST3 is the most similar to CoREST1. CoREST3 interaction with LSD1/KDM1A and HDAC1/2 resembles that of CoREST1, and its transcriptional repression is abolished by HDAC inhibitors, as happens with CoREST1. Therefore, CoREST3 could be functionally redundant with CoREST1. Nonetheless, CoREST3 exhibited a significantly lower repressive capacity than CoREST1, implying that CoREST3 likely has functions other than a role redundant with that of CoREST1. The small but significant decrease in catalytic efficiency (especially with regard to the higher K m value) might contribute to a lower transcriptional repressive action of the LSD1/KDM1A-CoREST3 complex.
Three lines of evidence indicate that complexes formed with CoREST2 are different from those formed with CoREST1 or CoREST3: (i) CoREST2-dependent transcriptional repression is not inhibited by SAHA or TSA, (ii) CoREST2 immunocomplexes display significantly lower HDAC activity than those constituted by CoREST1 or CoREST3, and (iii) coimmunoprecipitation assays show that the interaction of CoREST2 with HDAC1/2 is significantly lower than those exhibited by CoREST1 or CoREST3. On the other hand, the interaction between CoREST2 and LSD1/ KDM1A is similar to that of CoREST1 and CoREST3 with LSD1/ KDM1A. Supporting our data, a human complexome study showed strong interactions of LSD1/KDM1A with the 3 CoRESTs and of HDAC1 and HDAC2 with CoREST1 and CoREST3, but to a lesser extent with CoREST2 (40) .
Comparative protein sequence analysis among CoRESTs showed that amino acid differences exist, especially in the N-terminal portion of the ELM2 domain of CoREST2. Replacing the ELM2 of CoREST2 with the ELM2 of CoREST1 increased the interaction with HDAC2, and deleting the ELM2 abolished HDAC interaction and HDAC activity associated with CoREST2. Remarkably, we found that leucine 165 in the SANT1 domain of CoREST2 restricts the interaction of the ELM2 with HDACs. In fact, just replacing leucine 165 of CoREST2 with a serine, found in the equivalent position of CoREST1, enhanced both HDAC interaction and activity associated with CoREST2. These findings demonstrate that the ELM2 of CoREST2 is capable of interacting with HDACs. This interaction is controlled by specific features in the sequence of the SANT1 domain, in agreement with the notion that ELM2 and SANT domains are jointly responsible for the selection of and association with deacetylases in corepressors featuring this two-domain module. In this regard, Millard et al. (41) showed that the corepressor SMRT (silencing mediator for retinoid and thyroid hormone receptors) forms complexes with the class I histone deacetylase HDAC3 but not with HDAC1, whereas the core- pressor MTA1 (metastasis-associated protein 1) forms complexes with HDAC1 but not with HDAC3, despite the high homology between HDAC1 and HDAC3 (57% identical) (41) . MTA1, like CoREST proteins, presents an ELM2-SANT organization, whereas SMRT displays an ELM2-like-SANT organization (38, 41) , further supporting the significance of these domains in the specificity of the HDAC recruited in the transcriptional complexes. The findings showing that the ELM2-SANT1 region of the CoREST proteins determines the strength of the interaction with HDAC1/2 confirm CoRESTs as the HDAC recruiters in the complex and further highlights how finely tuned class I HDAC recruitment to different corepressor complexes is.
The data demonstrate that, unlike with CoREST1 and CoREST3, the transcriptional repression exerted by CoREST2 is HDAC independent. Actually, the mutant CoREST2⌬ELM2, which is unable to recruit HDACs and does not have associated HDAC activity, displayed the same repressor strength as wild-type CoREST2. Moreover, the mutant CoREST2L165S, which has a higher capacity to recruit HDACs, is not a better repressor than wild-type CoREST2, nor was its repression sensitive to HDAC inhibitors, strongly indicating that CoREST2 represses via an HDAC-independent mechanism. The CoREST2 mechanism of transcriptional repression may involve posttranslational modifications and/or specific CoREST2-interacting proteins, possibly including other kinds of deacetylases. Supporting distinctive features among CoRESTs, it was reported that CoREST1 binds directly and noncovalently to SUMO 2/3 peptides in a SUMO interaction motif (SIM)-dependent form; this characteristic is specific to CoREST1, since no SIM motifs were identified in CoREST3 and no association with SUMO was found for CoREST2 (42) .
Transcriptional complexes contain multiple interchangeable subunits, giving plasticity to gene expression regulation (43, 44) . The fact that the LSD1/KDM1A-CoREST2 complex is poor in HDAC1/2 content suggests that LSD1/KDM1A activity could be diminished in complexes with CoREST2, since LSD1/KDM1A demethylase function on the histone H3 tail is fully efficient only on deacetylated substrates (15, 24, 45, 46) . In addition, the fact that the LSD1/KDM1A-CoREST3 complex has a lower demethylase activity than the LSD1/KDM1A-CoREST1 complex suggests that the CoREST homolog controls the associated LSD1/KDM1A activity. Intriguingly, it was reported that CoREST2 could replace CoREST1 for efficient enzymatic reactions catalyzed by LSD1/ KDM1A on purified nucleosomes (28, 29) . Our data support the existence of higher-order protein complexes between CoRESTs. Coimmunoprecipitation assays indicate that CoREST1 has a strong tendency to interact with itself and to a lesser extent with CoREST2 and CoREST3, supporting a wider range of interactions and regulatory functions.
Increasing the complexity of existing mechanisms enhances the possibility of adapting and better responding to different stimuli. Our findings that CoREST2 and CoREST3 add different levels of control of HDAC1/2 recruitment and LSD1/KDM1A activity plus their abundance in the mature brain suggest that neuronal gene expression regulation by LCH complexes is a dynamic and finely tuned process. The physiological implications of this versatility in the constitution and transcriptional repression of complexes formed by members of the CoREST family remain to be determined.
